$7.69
-0.55-6.67%
At close: -
$7.69
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Entrada Therapeutics Insider Trading Activity | NASDAQ:TRDA | Benzinga
Track the latest Entrada Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Entrada Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Entrada Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On March 19, 2025, JAMES KORY WENTWORTH, the company's CHIEF FINANCIAL OFFICER sold 1.78K shares for $10.67 each.
Ownership Statistics for Entrada Therapeutics Inc
Shares Outstanding
37.953M
Insider Shares Owned
1.075M
Insider Percentage Owned
2.83%
Institutional Shares Held
9.523M
Institutional Percentage Held
25.1%
| Mar 19, 2025 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | -1.78K | $10.67 | -$19.04K | SELL | -1.60% | 109.54K | Mar 17 | View |
| Dec 12, 2024 | MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC | 10% OWNER | -44.72K | $20.51 | -$917.11K | SELL | -1.01% | 4.38M | Dec 10 - Dec 11 | View |
| Dec 12, 2024 | MPM BioVentures LPLUKE EVNINANSBERT GADICKETodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC | 10% OWNER | -44.72K | $20.51 | -$917.11K | SELL | -1.01% | 4.38M | Dec 10 - Dec 11 | View |
| Dec 03, 2024 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | 0.00 | $11.05 | -$107.35K | SELL-OPTIONS | 0.00% | 73.85K | Nov 29 - Dec 02 | View |
| Dec 03, 2024 | Natarajan Sethuraman | PRESIDENT, RESEARCH & DEVELOP. | -15.89K | $20.18 | -$320.62K | SELL | -9.88% | 145.00K | Nov 29 - Dec 03 | View |
| Nov 13, 2024 | Natarajan Sethuraman | PRESIDENT, RESEARCH & DEVELOP. | -4.11K | $20.03 | -$82.30K | SELL | -2.49% | 160.89K | Nov 11 - Nov 13 | View |
| Nov 13, 2024 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | -2.64K | $11.04 | -$159.96K | SELL | -3.45% | 73.85K | Nov 11 | View |
| Nov 06, 2024 | Natarajan Sethuraman | PRESIDENT, RESEARCH & DEVELOP. | -18.22K | $18.62 | -$339.28K | SELL | -9.94% | 165.00K | Nov 04 - Nov 06 | View |
| Oct 18, 2024 | Natarajan Sethuraman | PRESIDENT, RESEARCH & DEVELOP. | -600.00 | $18.00 | -$10.80K | SELL | -0.33% | 183.22K | Oct 16 | View |
| Sep 30, 2024 | Nathan Dowden | PRESIDENT & COO | -847.00 | $16.00 | -$13.55K | SELL | -0.67% | 125.15K | Sep 26 | View |
| Sep 10, 2024 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | -3.19K | $14.97 | -$47.83K | SELL | -4.01% | 76.49K | Sep 09 | View |
| Sep 10, 2024 | Nathan Dowden | PRESIDENT & COO | -2.30K | $15.09 | -$34.75K | SELL | -1.80% | 126.00K | Sep 06 - Sep 09 | View |
| Sep 10, 2024 | Natarajan Sethuraman | CHIEF SCIENTIFIC OFFICER | -3.24K | $15.12 | -$49.00K | SELL | -1.73% | 183.82K | Sep 06 - Sep 09 | View |
| Aug 20, 2024 | Nathan Dowden | PRESIDENT & COO | -7.10K | $9.00 | -$406.00K | SELL | -5.17% | 130.11K | Aug 16 | View |
| Jul 16, 2024 | Natarajan Sethuraman | CHIEF SCIENTIFIC OFFICER | -1.24K | $18.00 | -$22.28K | SELL | -0.65% | 188.81K | Jul 12 - Jul 15 | View |
| Jul 16, 2024 | Dipal Doshi | CEO | -1.90K | $17.84 | -$33.90K | SELL | -0.56% | 334.48K | Jul 12 - Jul 15 | View |
| Jul 10, 2024 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | -1.76K | $14.95 | -$26.28K | SELL | -2.11% | 81.41K | Jul 08 | View |
| Jun 14, 2024 | Dipal Doshi | CEO | -1.00K | $16.17 | -$16.17K | SELL | -0.30% | 336.38K | Jun 13 | View |
| May 20, 2024 | Natarajan Sethuraman | CHIEF SCIENTIFIC OFFICER | -18.98K | $15.16 | -$287.69K | SELL | -9.08% | 190.05K | May 16 - May 20 | View |
| May 20, 2024 | Dipal Doshi | CEO | -3.00K | $15.04 | -$45.13K | SELL | -0.88% | 337.38K | May 16 - May 17 | View |
| May 16, 2024 | PETER KIM | DIRECTOR | 25.00K | $14.59 | $364.67K | BUY | 37.09% | 92.41K | May 14 | View |
| May 10, 2024 | PETER KIM | DIRECTOR | 4.48K | $14.14 | $63.31K | BUY | 7.11% | 67.41K | May 08 - May 09 | View |
| Apr 10, 2024 | PETER KIM | DIRECTOR | 2.60K | $13.57 | $35.29K | BUY | 4.31% | 62.94K | Apr 08 | View |
| Apr 01, 2024 | PETER KIM | DIRECTOR | 1.51K | $13.75 | $20.79K | BUY | 2.57% | 60.34K | Mar 28 | View |
| Mar 26, 2024 | PETER KIM | DIRECTOR | 9.05K | $13.58 | $122.88K | BUY | 18.18% | 58.82K | Mar 22 - Mar 26 | View |
| Mar 21, 2024 | PETER KIM | DIRECTOR | 2.73K | $12.81 | $35.00K | BUY | 5.81% | 49.78K | Mar 19 - Mar 21 | View |
| Mar 08, 2024 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | -4.09K | $12.31 | -$50.29K | SELL | -5.22% | 74.17K | Mar 06 | View |
| Mar 08, 2024 | Nathan Dowden | PRESIDENT & COO | -1.83K | $12.32 | -$22.50K | SELL | -1.31% | 137.20K | Mar 06 | View |
| Feb 20, 2024 | Dipal Doshi | CEO | -1.00K | $15.00 | -$15.00K | SELL | -0.41% | 243.28K | Feb 15 | View |
| Jan 18, 2024 | Dipal Doshi | CEO | -1.00K | $15.99 | -$15.99K | SELL | -0.41% | 244.28K | Jan 16 | View |
| Dec 26, 2023 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | 0.00 | $8.84 | -$168.60K | SELL-OPTIONS | 0.00% | 49.57K | Dec 21 - Dec 26 | View |
| Dec 22, 2023 | Dipal Doshi | PRESIDENT AND CEO | -1.00K | $15.00 | -$15.00K | SELL | -0.41% | 245.28K | Dec 20 | View |
| Nov 13, 2023 | Dipal Doshi | PRESIDENT AND CEO | -1.00K | $16.23 | -$16.23K | SELL | -0.40% | 246.28K | Nov 13 | View |
| Oct 19, 2023 | Dipal Doshi | PRESIDENT AND CEO | -1.00K | $15.00 | -$15.00K | SELL | -0.40% | 247.28K | Oct 17 | View |
| Sep 15, 2023 | Dipal Doshi | PRESIDENT AND CEO | -1.00K | $15.00 | -$15.00K | SELL | -0.40% | 248.28K | Sep 13 | View |
| Sep 06, 2023 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | 12.82K | $13.78 | -$18.97K | GRANT | 34.90% | 49.57K | Sep 01 - Sep 06 | View |
| Sep 06, 2023 | NERISSA KREHER | CHIEF MEDICAL OFFICER | 12.91K | $13.78 | -$17.82K | GRANT | 47.57% | 40.04K | Sep 01 - Sep 06 | View |
| Sep 06, 2023 | Nathan Dowden | CHIEF OPERATING OFFICER | 12.79K | $13.77 | -$19.39K | GRANT | 36.16% | 48.17K | Sep 01 - Sep 06 | View |
| Aug 16, 2023 | Dipal Doshi | PRESIDENT AND CEO | -1.00K | $15.67 | -$15.67K | SELL | -0.49% | 201.07K | Aug 14 | View |
| Aug 04, 2023 | NERISSA KREHER | CHIEF MEDICAL OFFICER | 0.00 | $8.43 | -$338.13K | SELL-OPTIONS | 0.00% | 27.13K | Aug 02 - Aug 04 | View |
| Jul 12, 2023 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | 0.00 | $10.04 | -$158.86K | SELL-OPTIONS | 0.00% | 36.75K | Jul 10 - Jul 11 | View |
| Jul 12, 2023 | Nathan Dowden | CHIEF OPERATING OFFICER | -7.10K | $18.03 | -$127.94K | SELL | -16.71% | 35.38K | Jul 10 - Jul 11 | View |
| Jul 12, 2023 | Natarajan Sethuraman | CHIEF SCIENTIFIC OFFICER | -17.88K | $18.03 | -$322.39K | SELL | -10.44% | 153.45K | Jul 10 - Jul 11 | View |
| Jun 23, 2023 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | 0.00 | $8.55 | -$225.90K | SELL-OPTIONS | 0.00% | 27.96K | Jun 21 | View |
| Jun 22, 2023 | Nathan Dowden | CHIEF OPERATING OFFICER | -15.98K | $15.42 | -$246.40K | SELL | -27.34% | 42.47K | Jun 20 - Jun 22 | View |
| May 01, 2023 | Dipal Doshi | PRESIDENT AND CEO | -2.00K | $13.71 | -$27.42K | SELL | -0.98% | 202.07K | Apr 27 | View |
| Apr 19, 2023 | Dipal Doshi | PRESIDENT AND CEO | -2.09K | $18.01 | -$37.68K | SELL | -1.01% | 204.07K | Apr 17 | View |
| Apr 19, 2023 | Natarajan Sethuraman | CHIEF SCIENTIFIC OFFICER | -3.96K | $18.00 | -$71.32K | SELL | -2.26% | 171.32K | Apr 17 | View |
| Mar 29, 2023 | Dipal Doshi | PRESIDENT AND CEO | -2.00K | $14.72 | -$29.44K | SELL | -0.78% | 255.81K | Mar 27 | View |
| Mar 03, 2023 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | 25.65K | $10.92 | -$30.04K | GRANT | 155.36% | 42.16K | Mar 01 - Mar 02 | View |
| Mar 03, 2023 | NERISSA KREHER | CHIEF MEDICAL OFFICER | 25.81K | $10.94 | -$28.29K | GRANT | 166.37% | 41.33K | Mar 01 - Mar 02 | View |
| Mar 02, 2023 | Dipal Doshi | PRESIDENT AND CEO | -2.00K | $12.00 | -$24.00K | SELL | -1.22% | 161.84K | Feb 28 | View |
| Jan 30, 2023 | Dipal Doshi | PRESIDENT AND CEO | -2.00K | $12.00 | -$24.00K | SELL | -1.21% | 163.84K | Jan 27 | View |
| Jan 10, 2023 | Dipal Doshi | PRESIDENT AND CEO | -2.41K | $15.02 | -$36.20K | SELL | -1.43% | 165.84K | Jan 09 | View |
| Jan 03, 2023 | NERISSA KREHER | CHIEF MEDICAL OFFICER | -5.20K | $13.45 | -$69.93K | SELL | -25.10% | 15.52K | Dec 30 | View |
| Dec 29, 2022 | Dipal Doshi | PRESIDENT AND CEO | -14.59K | $15.02 | -$219.12K | SELL | -7.98% | 168.25K | Dec 27 - Dec 29 | View |
| Dec 12, 2022 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | 0.00 | $10.53 | -$76.68K | SELL-OPTIONS | 0.00% | 16.51K | Dec 08 | View |
| Dec 06, 2022 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | 0.00 | $10.14 | -$50.03K | SELL-OPTIONS | 0.00% | 16.51K | Dec 02 - Dec 05 | View |
| Nov 30, 2022 | Dipal Doshi | PRESIDENT AND CEO | -2.00K | $13.91 | -$27.83K | SELL | -1.08% | 182.84K | Nov 28 | View |
| Nov 18, 2022 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | 0.00 | $10.10 | -$3.20K | SELL-OPTIONS | 0.00% | 16.51K | Nov 16 | View |
| Nov 02, 2022 | Nathan Dowden | CHIEF OPERATING OFFICER | -2.10K | $24.05 | -$50.50K | SELL | -4.43% | 45.28K | Oct 31 | View |
| Oct 27, 2022 | NERISSA KREHER | CHIEF MEDICAL OFFICER | 0.00 | $11.69 | -$249.25K | SELL-OPTIONS | 0.00% | 20.72K | Oct 25 - Oct 26 | View |
| Oct 27, 2022 | Nathan Dowden | CHIEF OPERATING OFFICER | -9.35K | $20.77 | -$194.19K | SELL | -16.48% | 47.38K | Oct 25 | View |
| Oct 27, 2022 | Dipal Doshi | PRESIDENT AND CEO | -14.06K | $20.80 | -$292.51K | SELL | -7.07% | 184.84K | Oct 25 - Oct 27 | View |
| Oct 24, 2022 | Nathan Dowden | CHIEF OPERATING OFFICER | -6.08K | $18.66 | -$113.43K | SELL | -9.68% | 56.73K | Oct 20 - Oct 24 | View |
| Oct 24, 2022 | Dipal Doshi | PRESIDENT AND CEO | -5.94K | $18.64 | -$110.71K | SELL | -2.90% | 198.90K | Oct 20 - Oct 24 | View |
| Sep 28, 2022 | Dipal Doshi | PRESIDENT AND CEO | -10.59K | $15.25 | -$161.44K | SELL | -4.91% | 204.84K | Sep 26 - Sep 28 | View |
| Sep 28, 2022 | NERISSA KREHER | CHIEF MEDICAL OFFICER | 0.00 | $8.70 | -$113.38K | SELL-OPTIONS | 0.00% | 20.72K | Sep 26 - Sep 28 | View |
| Sep 28, 2022 | Nathan Dowden | CHIEF OPERATING OFFICER | -1.54K | $15.45 | -$23.85K | SELL | -2.40% | 62.81K | Sep 26 | View |
| Sep 23, 2022 | Dipal Doshi | PRESIDENT AND CEO | -4.42K | $15.10 | -$66.84K | SELL | -2.01% | 215.42K | Sep 21 - Sep 23 | View |
| Sep 23, 2022 | NERISSA KREHER | CHIEF MEDICAL OFFICER | 0.00 | $8.59 | -$55.57K | SELL-OPTIONS | 0.00% | 20.72K | Sep 21 - Sep 23 | View |
| Sep 23, 2022 | Nathan Dowden | CHIEF OPERATING OFFICER | -4.29K | $15.11 | -$64.88K | SELL | -6.25% | 64.36K | Sep 21 - Sep 23 | View |
| Sep 19, 2022 | Dipal Doshi | PRESIDENT AND CEO | -200.00 | $15.04 | -$3.01K | SELL | -0.09% | 219.85K | Sep 15 | View |
| Sep 19, 2022 | Nathan Dowden | CHIEF OPERATING OFFICER | -100.00 | $15.01 | -$1.50K | SELL | -0.15% | 68.65K | Sep 15 | View |
| Sep 19, 2022 | NERISSA KREHER | CHIEF MEDICAL OFFICER | 0.00 | $8.56 | -$1.37K | SELL-OPTIONS | 0.00% | 20.72K | Sep 15 | View |
| Sep 12, 2022 | Dipal Doshi | PRESIDENT AND CEO | -1.79K | $15.12 | -$27.04K | SELL | -0.81% | 220.05K | Sep 08 - Sep 09 | View |
| Sep 12, 2022 | NERISSA KREHER | CHIEF MEDICAL OFFICER | 0.00 | $8.60 | -$26.29K | SELL-OPTIONS | 0.00% | 20.72K | Sep 08 - Sep 09 | View |
| Sep 12, 2022 | Nathan Dowden | CHIEF OPERATING OFFICER | -1.78K | $15.11 | -$26.85K | SELL | -2.52% | 68.75K | Sep 08 - Sep 09 | View |
| Aug 31, 2022 | Dipal Doshi | PRESIDENT AND CEO | -2.00K | $12.72 | -$25.44K | SELL | -0.96% | 206.71K | Aug 29 - Aug 31 | View |
| Aug 26, 2022 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | -3.55K | $7.94 | -$62.02K | SELL | -24.43% | 10.99K | Aug 24 - Aug 25 | View |
| Aug 23, 2022 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | -5.68K | $7.59 | -$139.89K | SELL | -28.10% | 14.54K | Aug 19 - Aug 23 | View |
| Aug 18, 2022 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | -300.00 | $7.56 | -$7.18K | SELL | -1.46% | 20.22K | Aug 16 - Aug 18 | View |
| Jul 29, 2022 | Dipal Doshi | PRESIDENT AND CEO | -2.00K | $12.00 | -$24.00K | SELL | -0.95% | 208.71K | Jul 27 | View |
| Jun 29, 2022 | Nathan Dowden | CHIEF OPERATING OFFICER | -7.71K | $13.00 | -$100.28K | SELL | -10.62% | 64.89K | Jun 27 | View |
| Jun 29, 2022 | Dipal Doshi | PRESIDENT AND CEO | -4.00K | $12.00 | -$48.00K | SELL | -1.86% | 210.71K | Jun 27 | View |
| Jun 06, 2022 | BAKER BROS ADVISORS LPJULIAN BAKERFELIX BAKERBaker Bros Advisors GP LLC | 10% OWNER | 40.95K | $6.37 | $260.76K | BUY | 0.92% | 4.50M | Jun 02 - Jun 06 | View |
| May 24, 2022 | BAKER BROS ADVISORS LPJULIAN BAKERFELIX BAKERBaker Bros Advisors GP LLC | 10% OWNER | 48.51K | $5.82 | $282.45K | BUY | 1.10% | 4.47M | May 20 - May 24 | View |
| May 18, 2022 | BAKER BROS ADVISORS LPJULIAN BAKERFELIX BAKERBaker Bros Advisors GP LLC | 10% OWNER | 71.94K | $5.99 | $430.70K | BUY | 1.65% | 4.42M | May 16 - May 18 | View |
| Jan 13, 2022 | John Crowley | DIRECTOR | 5.00K | $9.71 | $48.58K | BUY | 15.21% | 37.86K | Jan 12 | View |
| Nov 05, 2021 | KUSH PARMAR | DIRECTOR | 4.08M | $20.00 | $5.00M | BUY | ∞ | 1.13M | Nov 02 | View |
| Nov 04, 2021 | AM Ventures V LPAM Partners V LLCAM Opportunities I LPAM Opportunities I GP LLCSCOTT ROCKLAGEAndrew Schwab | 10% OWNER | 4.08M | $20.00 | $5.00M | BUY | ∞ | 1.13M | Nov 02 | View |
| Nov 04, 2021 | Redmile Group LLCJeremy GreenRedmile Biopharma Investments III LP | 10% OWNER | 1.95M | $20.00 | $20.00M | BUY | ∞ | 1.95M | Nov 02 | View |
| Nov 04, 2021 | MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC | 10% OWNER | 4.43M | $20.00 | $2.00M | BUY | ∞ | 4.43M | Nov 02 | View |
| Nov 04, 2021 | MPM BioVentures LPLUKE EVNINANSBERT GADICKEMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC | 10% OWNER | 4.43M | $20.00 | $2.00M | BUY | ∞ | 4.43M | Nov 02 | View |
| Nov 04, 2021 | Todd Foley | DIRECTOR | 4.43M | $20.00 | $2.00M | BUY | ∞ | 4.43M | Nov 02 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
